TUESDAY, Oct. 27, 2020 -- Testing of Eli Lilly's antibody drug for hospitalized COVID-19 patients has been halted because the treatment doesn't help them recover from their infection.
Two weeks ago, enrollment in the study was paused because of a possible safety issue, the Associated Press reported. But the U.S. National Institute of Allergy and Infectious Diseases, which sponsored the Lilly study, pulled the plug on the trial Monday -- not because of any safety problem, but because there was only a slight chance that the drug would be effective, the AP said.
TUESDAY, Oct. 27, 2020 -- Stuck at home, bored. Fiddling with their phone or playing video games. Munching on snack foods to while away the time.
School-age children gaining excess pounds could be one lasting health problem caused by the COVID-19 pandemic, with pediatricians and public health experts warning about a potentially dramatic increase in childhood obesity.
TUESDAY, Oct. 27, 2020 -- Replacing sugary drinks with diet versions may not be any healthier for the heart, a large, new study suggests.
French researchers found that people who regularly drank artificially sweetened beverages had a higher risk of heart disease and stroke, versus people who avoided those beverages. In fact, they were no less likely to develop cardiovascular disease than people who regularly downed sugary drinks.
TUESDAY, Oct. 27, 2020 -- Many married couples or domestic partners share a lot: the same house, bills, pets and maybe children. A new study found they often also share the same behaviors and risk factors that can lead to heart disease.
Researchers assessed heart disease risks and lifestyle behaviors of nearly 5,400 U.S. couples enrolled in an employee wellness program.
TUESDAY, Oct. 27, 2020 -- Researchers in the United Kingdom have reassuring news for people with psoriasis based on the first analysis of a global registry of COVID-19 patients who also have the skin disease.
Moderate-to-severe cases of psoriasis are treated with drugs that suppress the immune system. This analysis of the international PsoProtect registry found that more than 90% of psoriasis patients survive infection with the new coronavirus.
TUESDAY, Oct. 27, 2020 -- Factors such as sex, age and severity of the disease may help identify COVID-19 survivors who have high levels of antibodies that can protect against the disease, a new study suggests.
"These were significant patient characteristics that not only predicted the amount of antibody but the quality of that antibody," said lead author Sabra Klein, a professor in the Department of Molecular Microbiology and Immunology at Johns Hopkins Bloomberg School of Public Health in Baltimore.